Row 13810

Row ID: 13810 | Dataset Entry | Axioma AXP Content Repository

Content Data

This page contains data entry 13810 from the Axioma AXP content repository. The structured data below represents the complete record for this entry.

"Interesting you cite the differences in form. Is the different form unrestricted by patent.."

- yes, because the conjugate form (semaglutide salt) is sold for research purposes only and not FDA approved for human consumption.

"or are they using the different form because the actual manner Wegovy constructs the medicine is too complex or expensive likely?"

- expensive and unavailable. Novo Nordisk holds the patent on semaglutide, and the drug maker DOES NOT supply the ingredient to outside groups, leaving some experts wondering what exactly is being sold to consumers. This is where the suspicion that they're using/selling a conjugate stems from. And several States have already begun cracking down on compounding pharmacies for using a non FDA approved form of semaglutide in their Wegovy/Ozempic knockoffs. See [(link)](https://www.nbcnews.com/health/health-news/ozempic-wegovy-weight-loss-compounded-crackdowns-rcna82405). Additionally Novo themselves have successfully brought multiple lawsuits against compounding pharmacies for patent infringement. See [(link)](https://www.nbcnews.com/health/health-news/novo-nordisk-settles-two-lawsuits-copycat-versions-ozempic-wegovy-rcna138075). And late last year, Novo Nordisk said that it had conducted tests on compounded products allegedly being sold as semaglutide from two Florida pharmacies as part of their lawsuits against compounders. One sample, the drug maker claimed, had a level of *unknown* impurities of 33%. Another sample had lower levels of the active ingredient than described on the label, along with *impurities*, according to a separate lawsuit. The FDA has not approved any compounded from of semaglutide and has issued warnings about counterfeit Wegovy/Ozempic. See [(link)](https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss#:~:text=Has%20FDA%20found%20illegally%20marketed,distribution%20of%20illegally%20marketed%20semaglutide.)

These links should help you further understand this complex and evolving landscape...

[Link: Compounding Pharmacies & Patents](https://www.mc-rx.com/compounded-semaglutide-is-it-worth-the-risk#:~:text=Obtaining%20semaglutide%20from%20a%20non,protected%20in%20the%20United%20States.)

[Link: lawsuits ](https://www.nbcnews.com/health/health-news/novo-nordisk-settles-two-lawsuits-copycat-versions-ozempic-wegovy-rcna138075)

[Link: Compounded (And Counterfeit) Semaglutide](https://www.science.org/content/blog-post/compounded-and-counterfeit-semaglutide)

FieldValue
text "Interesting you cite the differences in form. Is the different form unrestricted by patent.." - yes, because the conjugate form (semaglutide salt) is sold for research purposes only and not FDA approved for human consumption. "or are they using the different form because the actual manner Wegovy constructs the medicine is too complex or expensive likely?" - expensive and unavailable. Novo Nordisk holds the patent on semaglutide, and the drug maker DOES NOT supply the ingredient to outside gr…
label r/health
dataType comment
communityName r/Health
datetime 2024-05-20
username_encoded Z0FBQUFBQm5Lakw3NzRBc2VrZkJNTldHdERoODN4eXpLNUpRVE81eC1QT05BVnZQQXpoU3Y3d1lHMmdRY0RvaGZsVWlUV2xWM0JlVGJGQ19SS2lscndMNDhHbDZrS2NkMVV2R2NZSHdQeWJLS0ZVRGtMbWEzOTg9
url_encoded Z0FBQUFBQm5Lak9LakJPZW9NR2g3Nm9iMnJLaGtYVTZldHE0c3FFVWJzMTRKakx5cVVsZFV4VzRPQkxPV2JQQ1RacURhbk5YMzh0S0JFcEdsenpGR1dSdjFyZjRBRmhuZUFYWGxOcVRRaHpiYmliZTM5S18yTkh4ZGlPTkpGZFRfQXpYX25MSGd4RGo0ZWNnekNJaG9Kek40U1NIS3Mxd1NxWE9wTXZEQWVrTF9DakNycFdpaFVCZ2RNbGNsSXJmQ3NLYXp4S3VZLWxrZjZXQnlCOEV1VjUwYXhYdmg4SUI3QT09

Raw Record

{
  "text": "\"Interesting you cite the differences in form. Is the different form unrestricted by patent..\"\n\n- yes, because the conjugate form (semaglutide salt) is sold for research purposes only and not FDA approved for human consumption.\n\n\"or are they using the different form because the actual manner Wegovy constructs the medicine is too complex or expensive likely?\"\n\n- expensive and unavailable. Novo Nordisk holds the patent on semaglutide, and the drug maker DOES NOT supply the ingredient to outside groups, leaving some experts wondering what exactly is being sold to consumers. This is where the suspicion that they're using/selling a conjugate stems from. And several States have already begun cracking down on compounding pharmacies for using a non FDA approved form of semaglutide in their Wegovy/Ozempic knockoffs. See [(link)](https://www.nbcnews.com/health/health-news/ozempic-wegovy-weight-loss-compounded-crackdowns-rcna82405). Additionally Novo themselves have successfully brought multiple lawsuits against compounding pharmacies for patent infringement. See [(link)](https://www.nbcnews.com/health/health-news/novo-nordisk-settles-two-lawsuits-copycat-versions-ozempic-wegovy-rcna138075). And late last year, Novo Nordisk said that it had conducted tests on compounded products allegedly being sold as semaglutide from two Florida pharmacies as part of their lawsuits against compounders. One sample, the drug maker claimed, had a level of *unknown* impurities of 33%. Another sample had lower levels of the active ingredient than described on the label, along with *impurities*, according to a separate lawsuit. The FDA has not approved any compounded from of semaglutide and has issued warnings about counterfeit Wegovy/Ozempic. See [(link)](https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss#:~:text=Has%20FDA%20found%20illegally%20marketed,distribution%20of%20illegally%20marketed%20semaglutide.)\n\nThese links should help you further understand this complex and evolving landscape...\n\n[Link: Compounding Pharmacies & Patents](https://www.mc-rx.com/compounded-semaglutide-is-it-worth-the-risk#:~:text=Obtaining%20semaglutide%20from%20a%20non,protected%20in%20the%20United%20States.)\n\n[Link: lawsuits ](https://www.nbcnews.com/health/health-news/novo-nordisk-settles-two-lawsuits-copycat-versions-ozempic-wegovy-rcna138075)\n\n[Link: Compounded (And Counterfeit) Semaglutide](https://www.science.org/content/blog-post/compounded-and-counterfeit-semaglutide)",
  "label": "r/health",
  "dataType": "comment",
  "communityName": "r/Health",
  "datetime": "2024-05-20",
  "username_encoded": "Z0FBQUFBQm5Lakw3NzRBc2VrZkJNTldHdERoODN4eXpLNUpRVE81eC1QT05BVnZQQXpoU3Y3d1lHMmdRY0RvaGZsVWlUV2xWM0JlVGJGQ19SS2lscndMNDhHbDZrS2NkMVV2R2NZSHdQeWJLS0ZVRGtMbWEzOTg9",
  "url_encoded": "Z0FBQUFBQm5Lak9LakJPZW9NR2g3Nm9iMnJLaGtYVTZldHE0c3FFVWJzMTRKakx5cVVsZFV4VzRPQkxPV2JQQ1RacURhbk5YMzh0S0JFcEdsenpGR1dSdjFyZjRBRmhuZUFYWGxOcVRRaHpiYmliZTM5S18yTkh4ZGlPTkpGZFRfQXpYX25MSGd4RGo0ZWNnekNJaG9Kek40U1NIS3Mxd1NxWE9wTXZEQWVrTF9DakNycFdpaFVCZ2RNbGNsSXJmQ3NLYXp4S3VZLWxrZjZXQnlCOEV1VjUwYXhYdmg4SUI3QT09"
}
Explore Dataset Explore Row

Entry Information